Fibrogenic signalling in hepatic stellate cells
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
(1) Upon liver damage, hepatic stellate cells undergo a process defined as activation (Fig. 1), that enables them to acquire a myofibroblastic phenotype. The biological actions of myofibroblasts are pivotal for liver tissue repair and fibrogenesis [1]. (2) Activation of TGFb-dependent fibrogenic signalling in hepatic stellate cells. The source of TGFb is initially paracrine including hepatocytes, Kupffer cells, and platelets activated in response to hepatic injury [2]. (3) At the same time TLR4 signalling in hepatic stellate cells is required for down-regulation of TGFb pseudoreceptor (and inhibitor) BAMBI in order to render hepatic stellate cells sensitive to TGFb signalling. Bacterial-derived LPS is currently considered to be the key fibrogenic TLR4 ligand; however, additional endogenous ligands from damaged and dying hepatocytes cannot yet be ruled out as playing a role [3]. (4) TGFb signals generate transcriptional active pro-fibrogenic Smad2 and Smad3 complexes [2], but also stimulates collagen transcription in hepatic stellate cells via hydrogen peroxide and C/EBPb. (5) Transcription factors Sp1 and KLF6 stimulate TGFb gene transcription in hepatic stellate cells to provide autocrine fibrogenic signalling. (6) Accumulation of fibrillar matrix is facilitated by increased expression of tissue inhibitors of metalloproteinases (TIMPs). (7) Agonists of the nuclear receptor PPARc oppose TGFb signalling by inhibiting activation of hepatic stellate cells and collagen expression. PPARc expression is diminished during activation of hepatic stellate cells by an epigenetic mechanism involving the methylCpG binding protein MeCP2. Ongoing clinical trials with PPARc agonists will determine their efficacy as anti-fibrotics [4]. (8) Kupffer cells and damaged hepatocytes generate reactive oxygen species (ROS) [5] which stimulate hepatic stellate cell expression of chemokines and amplification of inflammation by an NF-jB-dependent pathway. (9) Paracrine and autocrine PDGF signalling [1,5] via PI3 Kinase and ERK serves to perpetuate hepatic stellate cell activa-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 3×
“(9) Paracrine and autocrine PDGF signalling [1,5] via PI3 Kinase and ERK serves to perpetuate hepatic stellate cell activa-”
BackgroundModels of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866 · cited 1×
“(14) Increased expression of MMPs is a critical event in the process of fibrosis reversal [8], and macrophage populations contribute to MMP expression.”
BackgroundGressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00292.x · Cited by 718 · cited 2×
“(4) TGFb signals generate transcriptional active pro-fibrogenic Smad2 and Smad3 complexes [2], but also stimulates collagen transcription in hepatic stellate cells via hydrogen peroxide and C/EBPb.”
BackgroundTranscriptional regulation of hepatic stellate cells
Mann, J., & Mann, D. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.011 · Cited by 119
Self-citation
Cited by
Adaptive immunity in HBV infection
Bertoletti, A., & Ferrari, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.026 · Cited by 483
Hypercoagulability in cirrhosis: causes and consequences
TRIPODI, A., ANSTEE, Q. M., SOGAARD, K. K., PRIMIGNANI, M., & VALLA, D. C. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04429.x · Cited by 295
Chronopoulos, A., Robinson, B., Sarper, M., Cortes, E., Auernheimer, V., Lachowski, D., Attwood, S., García, R., Ghassemi, S., Fabry, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12630 · Cited by 274
Xiang, D.-M., Sun, W., Ning, B.-F., Zhou, T.-F., Li, X.-F., Zhong, W., Cheng, Z., Xia, M.-Y., Wang, X., Deng, X., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313392 · Cited by 229
FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxis
Lachowski, D., Cortes, E., Robinson, B., Rice, A., Rombouts, K., & Del Río Hernández, A. E. (2018) · The FASEB Journal · doi:10.1096/fj.201700721r · Cited by 175
Metadata
- Authors
- Mann, D. A., & Marra, F.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 52
- Issue
- 6
- Pages
- 949-950
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2037583911
- Cited by
- 58
- References
- 4
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fibrogenic signalling in hepatic stellate cells. https://app.cochat.ai/papers/10.1016/j.jhep.2010.02.005
- The paper
- Mann, D. A., & Marra, F. (2010). Fibrogenic signalling in hepatic stellate cells. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2010.02.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.